Lower Prolactin Levels During Cabergoline Treatment are Associated to Tumor Shrinkage in Prolactin Secreting Pituitary Adenoma

导出原文传递

翻译打印收藏纠错

作者： Lombardi, M. ^[1] ; Lupi, I. ^[2] ; Cosottini, M. ^[3] ; Rossi, G. ; Manetti, L. ; Raffaelli, V. ; Sardella, C. ; Martino, E. ; Bogazzi, F.

作者单位： Univ Pisa, Dept Translat Res & New Technol Med & Surg, I-56124 Pisa, Italy ^[1] Univ Pisa, Dept Clin & Expt Med, I-56124 Pisa, Italy ^[2] CNR, Inst Clin Physiol, Epidemiol & Biostat Unit, Pisa, Italy ^[3]

关键词 PRL-secreting adenoma PRL dopamine agonists

发布时间 2015-03-17

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Hormone and Metabolic Research

2014年46卷13期

939-942页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Lower Prolactin Levels During Cabergoline Treatment are Associated to Tumor Shrinkage in Prolactin Secreting Pituitary Adenoma

Hormone and Metabolic Research

相似文献

Hormone and Metabolic Research

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Lower Prolactin Levels During Cabergoline Treatment are Associated to Tumor Shrinkage in Prolactin Secreting Pituitary Adenoma

Hormone and Metabolic Research

相似文献

Hormone and Metabolic Research

相关期刊

检索历史清除